{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:56:24Z","timestamp":1771631784571,"version":"3.50.1"},"publisher-location":"Cham","reference-count":258,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319690742","type":"print"},{"value":"9783319690759","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-69075-9_9","type":"book-chapter","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T08:13:11Z","timestamp":1526371991000},"page":"317-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["How to Succeed in Marketing Marine Natural Products for Nutraceutical, Pharmaceutical and Cosmeceutical Markets"],"prefix":"10.1007","author":[{"given":"Ricardo","family":"Calado","sequence":"first","affiliation":[]},{"given":"Miguel Costa","family":"Leal","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Maria Leonor","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Vieira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.1230318","volume":"339","author":"MJ Costello","year":"2013","unstructured":"Costello MJ, May RM, Stork NE (2013) Can we name Earth\u2019s species before they go extinct? Science 339:413\u2013416","journal-title":"Science"},{"key":"9_CR2","volume-title":"Safeguarding the health of oceans","author":"AP McGinn","year":"1999","unstructured":"McGinn AP (1999) Safeguarding the health of oceans, vol 145. Worldwatch Institute, Danvers"},{"issue":"2","key":"9_CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ddr.430330213","volume":"33","author":"DJ Devries","year":"1994","unstructured":"Devries DJ, Hall MR (1994) Marine biodiversity as a source of chemical diversity. Drug Dev Res 33(2):161\u2013173","journal-title":"Drug Dev Res"},{"issue":"1","key":"9_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030580.t003","volume":"7","author":"MC Leal","year":"2012","unstructured":"Leal MC, Puga J, Ser\u00f4dio J, Gomes NCM, Calado R (2012) Trends in the discovery of new marine natural products from invertebrates over the last two decades \u2013 where and what are we bioprospecting? PLoS One 7(1):e30580. https:\/\/doi.org\/10.1371\/journal.pone.0030580.t003","journal-title":"PLoS One"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1039\/c3np70057g","volume":"30","author":"MC Leal","year":"2013","unstructured":"Leal MC, Munro MHG, Blunt JW et al (2013) Biogeography and biodiscovery hotspots of macroalgal marine natural products. Nat Prod Rep 30:1380\u20131390","journal-title":"Nat Prod Rep"},{"issue":"12","key":"9_CR6","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.4155\/fmc.11.118","volume":"3","author":"R Montaser","year":"2011","unstructured":"Montaser R, Luesch H (2011) Marine natural products: a new wave of drugs? Future Med Chem 3(12):1475\u20131489. https:\/\/doi.org\/10.4155\/fmc.11.118","journal-title":"Future Med Chem"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/md12021066","volume":"12","author":"A Martins","year":"2014","unstructured":"Martins A, Vieira H, Gaspar H, Santos S (2014) Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Mar Drugs 12:1066\u20131101","journal-title":"Mar Drugs"},{"issue":"3","key":"9_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/np200906s","volume":"75","author":"DJ Newman","year":"2012","unstructured":"Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75(3):311\u2013335. https:\/\/doi.org\/10.1021\/np200906s","journal-title":"J Nat Prod"},{"issue":"5","key":"9_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biotechadv.2011.03.001","volume":"29","author":"JF Imhoff","year":"2011","unstructured":"Imhoff JF, Labes A, Wiese J (2011) Bio-mining the microbial treasures of the ocean: new natural products. Biotechnol Adv 29(5):468\u2013482. https:\/\/doi.org\/10.1016\/j.biotechadv.2011.03.001","journal-title":"Biotechnol Adv"},{"key":"9_CR10","volume-title":"Marine biotechnology in the twenty-first century: problems, promise and products","author":"National Research Council","year":"2002","unstructured":"National Research Council (2002) Marine biotechnology in the twenty-first century: problems, promise and products. National Academies Press, Washington, DC"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-1656(99)00052-8","volume":"70","author":"M Munro","year":"1999","unstructured":"Munro M, Blunt JW, Dumdei E et al (1999) The discovery and development of marine compounds with pharmaceutical potential. J Biotechnol 70:15\u201325","journal-title":"J Biotechnol"},{"issue":"8","key":"9_CR12","doi-asserted-by":"publisher","first-page":"9842","DOI":"10.3390\/molecules17089842","volume":"17","author":"MC Leal","year":"2012","unstructured":"Leal MC, Madeira C, Brandao CA, Puga J, Calado R (2012) Bioprospecting of marine invertebrates for new natural products \u2013 a chemical and zoogeographical perspective. Molecules 17(8):9842\u20139854. https:\/\/doi.org\/10.3390\/molecules17089842","journal-title":"Molecules"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1039\/C5NP00130G","volume":"33","author":"MC Leal","year":"2016","unstructured":"Leal MC, Hil\u00e1rio A, Munro HG, Blunt JW, Calado R (2016) Natural products discovery needs improved taxonomic and geographic information. Nat Prod Rep 33:747\u2013750","journal-title":"Nat Prod Rep"},{"key":"9_CR14","first-page":"608","volume":"7","author":"E Lederer","year":"1940","unstructured":"Lederer E, Teissier G, Huttrer C (1940) The isolation and chemical composition of calliactine, pigment of the sea anemone \u201cSargatia parasitica\u201d (Calliactis effoeta). Bull Soc Chim Fr 7:608\u2013615","journal-title":"Bull Soc Chim Fr"},{"key":"9_CR15","unstructured":"MarinLit: A database of the marine natural products literature (2016)"},{"issue":"6","key":"9_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1039\/b808743a","volume":"25","author":"D Skropeta","year":"2008","unstructured":"Skropeta D (2008) Deep-sea natural products. Nat Prod Rep 25(6):1131\u20131166. https:\/\/doi.org\/10.1039\/b808743a","journal-title":"Nat Prod Rep"},{"issue":"2","key":"9_CR17","first-page":"189","volume":"12","author":"AD Kinghorn","year":"2009","unstructured":"Kinghorn AD, Chin Y-W, Swanson SM (2009) Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Dev 12(2):189\u2013196","journal-title":"Curr Opin Drug Discov Dev"},{"key":"9_CR18","unstructured":"WoRMS Editorial Board (2016) World register of marine species. http:\/\/www.marinespecies.org at VLIZ. Accessed 19 Dec 2016. doi:10.14284\/170"},{"issue":"12","key":"9_CR19","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S1359-6446(03)02713-2","volume":"8","author":"B Haefner","year":"2003","unstructured":"Haefner B (2003) Drugs from the deep: marine natural products as drug candidates. Drug Discov Today 8(12):536\u2013544. https:\/\/doi.org\/10.1016\/S1359-6446(03)02713-2","journal-title":"Drug Discov Today"},{"key":"9_CR20","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.3390\/md12073929","volume":"12","author":"MC Leal","year":"2014","unstructured":"Leal MC, Sheridan C, Osinga R et al (2014) Marine microorganism-invertebrate assemblages: perspectives to solve the \u201csupply problem\u201d in the initial steps of drug discovery. Mar Drugs 12:3929\u20133952","journal-title":"Mar Drugs"},{"key":"9_CR21","first-page":"4","volume":"45","author":"GR Pettit","year":"1982","unstructured":"Pettit GR, Fujii Y, Hasler JA, Schmidt JM (1982) Isolation and characterization of palystatins A\u2013D. J Nat Prod 45:4","journal-title":"J Nat Prod"},{"key":"9_CR22","volume-title":"Marine cosmeceuticals: trends and prospects","year":"2012","unstructured":"Kim S-K (ed) (2012) Marine cosmeceuticals: trends and prospects. CRC Press, Taylor & Francis Group, Boca Raton, FL"},{"key":"9_CR23","volume-title":"Marine biotechnology strategic research and innovation roadmap: insights to the future direction of European marine biotechnology","author":"D Hurst","year":"2016","unstructured":"Hurst D, B\u00f8rresen T, Almesj\u00f6 L, De Raedemaecker F, Bergseth S (2016) Marine biotechnology strategic research and innovation roadmap: insights to the future direction of European marine biotechnology, 1st edn. Marine Biotechnology ERA-NET, Oostende","edition":"1"},{"issue":"9","key":"9_CR24","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.foodres.2010.08.005","volume":"43","author":"Eva G\u00f3mez-Ord\u00f3\u00f1ez","year":"2010","unstructured":"Gomez-Ordonez E, Jimenez-Escrig A, Ruperez P (2010) Dietary fibre and physico-chemical properties of several edible seaweeds from the North western Spanish coast. Food Res Int (9):2289\u20132294","journal-title":"Food Research International"},{"issue":"1","key":"9_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.tifs.2007.07.012","volume":"19","author":"M Plaza","year":"2008","unstructured":"Plaza M, Cifuentes A, Ibanez E (2008) In the search of new functional food ingredients from algae. Trends Food Sci Technol 19(1):31\u201339. https:\/\/doi.org\/10.1016\/j.tifs.2007.07.012","journal-title":"Trends Food Sci Technol"},{"issue":"4","key":"9_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0271-5317(00)00149-4","volume":"20","author":"A Jimenez-Escrig","year":"2000","unstructured":"Jimenez-Escrig A, Sanchez-Muniz FJ (2000) Dietary fibre from edible seaweeds: chemical structure, physicochemical properties and effects on cholesterol metabolism. Nutr Res 20(4):585\u2013598. https:\/\/doi.org\/10.1016\/S0271-5317(00)00149-4","journal-title":"Nutr Res"},{"key":"9_CR27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s002170000264","volume":"212","author":"P Ruperez","year":"2001","unstructured":"Ruperez P, Saura-Calixto F (2001) Dietary fibre and physicochemical properties of edible Spanish seaweeds. Eur Food Res Technol 212:349\u2013354","journal-title":"Eur Food Res Technol"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/md9040514","volume":"9","author":"GP Hu","year":"2011","unstructured":"Hu GP, Yuan J, Sun L et al (2011) Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 9:514\u2013525","journal-title":"Mar Drugs"},{"key":"9_CR29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tifs.2008.08.004","volume":"20","author":"F Shahidi","year":"2009","unstructured":"Shahidi F (2009) Nutraceuticals and functional foods: whole versus processed foods. Trends Food Sci Technol 20:376\u2013387","journal-title":"Trends Food Sci Technol"},{"key":"9_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/047167849X","volume-title":"Bailey\u2019s industrial oil and fat products","author":"F Shahidi","year":"2005","unstructured":"Shahidi F, Zhong Y (2005) Marine mammal oils. In: Bailey\u2019s industrial oil and fat products, 6th edn. Wiley, New York, pp 259\u2013278","edition":"6"},{"key":"9_CR31","unstructured":"Foundation ES (2010) Marine biotechnology: a new vision and strategy for Europe Marine Board. ESF Position Paper n\u00b0 15:96"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.foodchem.2014.08.044","volume":"170","author":"C Afonso","year":"2015","unstructured":"Afonso C, Costa S, Cardoso C et al (2015) Evaluation of the risk\/benefit associated to the consumption of raw and cooked farmed meagre based on the bioaccessibility of selenium, eicosapentaenoic acid and docosahexaenoic acid, total mercury, and methylmercury determined by an in vitro digestion model. Food Chem 170:249\u2013256. https:\/\/doi.org\/10.1016\/j.foodchem.2014.08.044","journal-title":"Food Chem"},{"issue":"1","key":"9_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.plipres.2010.07.004","volume":"50","author":"G Kaur","year":"2011","unstructured":"Kaur G, Cameron-Smith D, Garg M, Sinclair AJ (2011) Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog Lipid Res 50(1):28\u201334. https:\/\/doi.org\/10.1016\/j.plipres.2010.07.004","journal-title":"Prog Lipid Res"},{"key":"9_CR34","volume-title":"Fatty acids: types, roles and health effects","author":"NM Bandarra","year":"2011","unstructured":"Bandarra NM, Batista I, Nunes ML (2011) In: Chen G (ed) Fatty acids: types, roles and health effects. Nova Science, Hauppauge, NY (ebook)"},{"issue":"4","key":"9_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/lite.201500013","volume":"27","author":"OA Byelashov","year":"2015","unstructured":"Byelashov OA, Sinclair AJ, Kaur G (2015) Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid. Lipid Technol 27(4):79\u201382. https:\/\/doi.org\/10.1002\/lite.201500013","journal-title":"Lipid Technol"},{"issue":"6","key":"9_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/md9061056","volume":"9","author":"S Lordan","year":"2011","unstructured":"Lordan S, Ross RP, Stanton C (2011) Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic diseases. Mar Drugs 9(6):1056\u20131100. https:\/\/doi.org\/10.3390\/md9061056","journal-title":"Mar Drugs"},{"issue":"4","key":"9_CR37","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ijbiomac.2012.06.001","volume":"51","author":"DH Ngo","year":"2012","unstructured":"Ngo DH, Vo TS, Ngo DN, Wijesekara I, Kim SK (2012) Biological activities and potential health benefits of bioactive peptides derived from marine organisms. Int J Biol Macromol 51(4):378\u2013383. https:\/\/doi.org\/10.1016\/j.ijbiomac.2012.06.001","journal-title":"Int J Biol Macromol"},{"key":"9_CR38","first-page":"1422","volume":"45","author":"S Shukla","year":"2016","unstructured":"Shukla S (2016) Therapeutic importance of peptides from marine source: a mini review. Ind J Geo-Mar Sci 45:1422\u20131431","journal-title":"Ind J Geo-Mar Sci"},{"issue":"10","key":"9_CR39","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/md13106336","volume":"13","author":"HA Suleria","year":"2015","unstructured":"Suleria HA, Osborne S, Masci P, Gobe G (2015) Marine-based nutraceuticals: an innovative trend in the food and supplement industries. Mar Drugs 13(10):6336\u20136351. https:\/\/doi.org\/10.3390\/md13106336","journal-title":"Mar Drugs"},{"issue":"15","key":"9_CR40","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1001\/jama.296.15.1885","volume":"296","author":"D Mozaffarian","year":"2006","unstructured":"Mozaffarian D, Rimm EB (2006) Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 296(15):1885\u20131899. https:\/\/doi.org\/10.1001\/jama.296.15.1885","journal-title":"JAMA"},{"issue":"1","key":"9_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2006.02.012","volume":"189","author":"EM Balk","year":"2006","unstructured":"Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189(1):19\u201330. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.02.012","journal-title":"Atherosclerosis"},{"issue":"6 Suppl","key":"9_CR42","doi-asserted-by":"crossref","first-page":"1505S","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"PC Calder","year":"2006","unstructured":"Calder PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83(6 Suppl):1505S\u20131519S","journal-title":"Am J Clin Nutr"},{"issue":"1 Suppl","key":"9_CR43","doi-asserted-by":"crossref","first-page":"200S","DOI":"10.1093\/jn\/137.1.200S","volume":"137","author":"RS Chapkin","year":"2007","unstructured":"Chapkin RS, Davidson LA, Ly L, Weeks BR, Lupton JR, McMurray DN (2007) Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr 137(1 Suppl):200S\u2013204S","journal-title":"J Nutr"},{"issue":"10","key":"9_CR44","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1158\/0008-5472.CAN-04-4200","volume":"65","author":"H Sun","year":"2005","unstructured":"Sun H, Berquin IM, Edwards IJ (2005) Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Res 65(10):4442\u20134447. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4200","journal-title":"Cancer Res"},{"issue":"15","key":"9_CR45","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/jnci\/djt174","volume":"105","author":"TM Brasky","year":"2013","unstructured":"Brasky TM, Darke AK, Song X et al (2013) Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. J Natl Cancer Inst 105(15):1132\u20131141. https:\/\/doi.org\/10.1093\/jnci\/djt174","journal-title":"J Natl Cancer Inst"},{"key":"9_CR46","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1111\/j.1753-4887.2006.tb00242.x","volume":"64","author":"Ricardo Uauy","year":"2008","unstructured":"Uauy R, Dangour AD (2006) Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 64(5 Pt 2):S24\u2013S33; discussion S72\u2013S91","journal-title":"Nutrition Reviews"},{"issue":"8","key":"9_CR47","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2165\/00003495-200565080-00002","volume":"65","author":"M Peet","year":"2005","unstructured":"Peet M, Stokes C (2005) Omega-3 fatty acids in the treatment of psychiatric disorders. Drugs 65(8):1051\u20131059","journal-title":"Drugs"},{"issue":"7","key":"9_CR48","first-page":"48","volume":"10","author":"EFSA Panel on Dietetic Products NaAN","year":"2012","unstructured":"EFSA Panel on Dietetic Products NaAN (2012) Scientific opinion related to the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J 10(7):48","journal-title":"EFSA J"},{"key":"9_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jff.2008.09.006","volume":"1","author":"CJ Barrow","year":"2009","unstructured":"Barrow CJ, Nolan C, MacLead M, Santosa S, Holub BJ (2009) Bioequivalence of encapsulated and microencapsulated fish-oil supplementation. J Funct Foods 1:38\u201343","journal-title":"J Funct Foods"},{"key":"9_CR50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jfoodeng.2013.01.011","volume":"117","author":"Q Chen","year":"2013","unstructured":"Chen Q, McGillivray D, Wen J, Zhong F, Quek S (2013) Co-encapsulation of fish oil with phytosterol esters and limonene by milk proteins. J Food Eng 117:505\u2013512","journal-title":"J Food Eng"},{"key":"9_CR51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/lite.201600002","volume":"28","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Judeh ZMA (2016) Microencapsulation of fish oil. Lipid Technol 28:13\u201315","journal-title":"Lipid Technol"},{"key":"9_CR52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-3-662-09836-3_14","volume-title":"Seafoods: quality, technology and nutraceutical applications","author":"UN Wanasundara","year":"2002","unstructured":"Wanasundara UN, Wanasundara J, Shahidi F (2002) Omega-3 fatty acid concentrates: a review of production technologies. In: Alasalvarand C, Taylor T (eds) Seafoods: quality, technology and nutraceutical applications. Springer, New York, pp 157\u2013174"},{"issue":"10","key":"9_CR53","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2903\/j.efsa.2010.1874","volume":"8","author":"(BIOHAZ) EPoCH","year":"2010","unstructured":"(BIOHAZ) EPoCH (2010) Scientific opinion on fish oil for human consumption. Food hygiene, including rancidity. EFSA J 8(10):1874","journal-title":"EFSA J"},{"key":"9_CR54","unstructured":"Beer C (2011) Krill: the ocean\u2019s gold. Nutraceuticals World. http:\/\/www.nutraceuticalsworld.com\/contents\/view_features\/2011-10-03\/krill-the-oceans-gold"},{"key":"9_CR55","unstructured":"Corporation (U.S.) (2006) https:\/\/www.mordorintelligence.com\/industry-reports\/global-nutraceuticals-market-industrygclid=CMOdrsr2lNECFQafGwodDugLyw . Accessed Dec 2016"},{"key":"9_CR56","unstructured":"Moloughney S (2011) Diving deep into the marine nutraceuticals market \u2013 consumers continue to ride the ocean\u2019s waves to better health. Nutraceuticals World. October, p 44\u201352. http:\/\/www.nutraceuticalsworld.com\/contents\/view_features\/2011-10-03\/diving-deep-into-the-marine-nutraceuticals-market"},{"key":"9_CR57","first-page":"23","volume":"65","author":"CM Lee","year":"2012","unstructured":"Lee CM, Barrow CJ, Kim S, Miyashita K, Shahidi F (2012) Global trends in marine nutraceuticals. Food Technol 65:23\u201331","journal-title":"Food Technol"},{"key":"9_CR58","first-page":"566","volume-title":"Advances in seafood byproducts: 2002 Conference proceedings Alaska Sea Grant College Program","author":"F Shahidi","year":"2003","unstructured":"Shahidi F (2003) Nutraceuticals and bioactives from seafood byproducts. In: Bechtel PJ (ed) Advances in seafood byproducts: 2002 Conference proceedings Alaska Sea Grant College Program. University of Alaska Fairbanks, Fairbanks, p 566"},{"key":"9_CR59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.foodres.2005.10.010","volume":"39","author":"SK Kim","year":"2006","unstructured":"Kim SK, Mendis E (2006) Bioactive compounds from marine processing byproducts \u2013 a review. Food Res Int 39:383\u2013393","journal-title":"Food Res Int"},{"key":"9_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jff.2010.01.003","volume":"2","author":"SK Kim","year":"2010","unstructured":"Kim SK, Wijesekara I (2010) Development and biological activities of marine-derived bioactive peptides: a review. J Funct Foods 2:1\u20139","journal-title":"J Funct Foods"},{"key":"9_CR61","unstructured":"FAO (2016) The state of world fisheries and aquaculture 2016. Contributing to food security and nutrition for all, Rome"},{"key":"9_CR62","first-page":"876","volume-title":"Handbook of seafood quality, safety and health applications","author":"ML Nunes","year":"2011","unstructured":"Nunes ML, Bandarra NM, Batista I (2011) Health benefits associated with seafood consumption. In: Alasalvar C, Shahidi F, Miyashita K, Wanasundara U (eds) Handbook of seafood quality, safety and health applications, vol 122. Blackwell, Oxford, pp 876\u2013883"},{"issue":"9","key":"9_CR63","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.109.915165","volume":"122","author":"AM Bernstein","year":"2010","unstructured":"Bernstein AM, Sun Q, Hu FB, Stampfer MJ, Manson JE, Willett WC (2010) Major dietary protein sources and risk of coronary heart disease in women. Circulation 122(9):876\u2013883. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.915165","journal-title":"Circulation"},{"issue":"1","key":"9_CR64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/diabetes.52.1.29","volume":"52","author":"F Tremblay","year":"2003","unstructured":"Tremblay F, Lavigne C, Jacques H, Marette A (2003) Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase\/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes 52(1):29\u201337","journal-title":"Diabetes"},{"issue":"5","key":"9_CR65","doi-asserted-by":"crossref","first-page":"1558S","DOI":"10.1093\/ajcn\/87.5.1558S","volume":"87","author":"D Paddon-Jones","year":"2008","unstructured":"Paddon-Jones D, Westman E, Mattes RD, Wolfe RR, Astrup A, Westerterp-Plantenga M (2008) Protein, weight management, and satiety. Am J Clin Nutr 87(5):1558S\u20131561S","journal-title":"Am J Clin Nutr"},{"key":"9_CR66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1201\/9781420028041.ch3","volume-title":"Surimi and surimi seafood","author":"HO Hultin","year":"2005","unstructured":"Hultin HO, Kristinsson HG, Lanier TC, Park JW (2005) Process for recovery of functional proteins by pH shifts. In: Park JW (ed) Surimi and surimi seafood. CRC Press, Boca Raton, FL, pp 107\u2013139"},{"key":"9_CR67","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.foodchem.2010.06.078","volume":"124","author":"CK Gehring","year":"2011","unstructured":"Gehring CK, Gigliotti JC, Moritz JS, Tou JC, Jaczynski J (2011) Functional and nutritional characteristics of proteins and lipids recovered by isoelectric processing of fish by-products and low-value fish: a review. Food Chem 124:422\u2013431","journal-title":"Food Chem"},{"key":"9_CR68","unstructured":"Hultin HO, Kelleher SD (1999) Process for isolating a protein composition from a muscle source and protein composition. US Patent 6,005,073"},{"key":"9_CR69","unstructured":"Hultin HO, Kelleher SD (2000) High efficiency alkaline protein extraction. US Patent 6,136,959"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0308-8146(01)00328-4","volume":"77","author":"B Jamilah","year":"2002","unstructured":"Jamilah B, Harvinder KG (2002) Properties of gelatins from skins of fish \u2013 black tilapia (Oreochromis mossambicus) and red tilapia (Oreochromis nilotica). J Food Chem 77:81\u201384","journal-title":"J Food Chem"},{"key":"9_CR71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.foodhyd.2008.07.002","volume":"23","author":"AA Karim","year":"2009","unstructured":"Karim AA, Bhat R (2009) Fish gelatin: properties, challenges, and prospects as an alternative to mammalian gelatins. Food Hydrocoll 23:563\u2013576","journal-title":"Food Hydrocoll"},{"key":"9_CR72","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.procbio.2004.07.011","volume":"40","author":"SI Aspmo","year":"2005","unstructured":"Aspmo SI, Horn SJ, Eijsink VGH (2005) Enzymatic hydrolysis of Atlantic cod (Gadus morhua L.) viscera. Process Biochem 40:1957\u20131966","journal-title":"Process Biochem"},{"key":"9_CR73","unstructured":"Batista I, Pires C, Teixeira B, Nunes ML (2014) Hidrolisados proteicos com atividade biol\u00f3gica: uma alternativa para a valoriza\u00e7\u00e3o de subprodutos de pescado. Boletim de Biotecnologia 2\u00aa S\u00e9rie(5):37\u201339"},{"key":"9_CR74","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1381-1177(00)00031-X","volume":"11","author":"F Gu\u00e9rard","year":"2001","unstructured":"Gu\u00e9rard F, Dufoss\u00e9 L, De La Broise D, Binet A (2001) Enzymatic hydrolysis of proteins from yellowfin tuna (Thunnus albacares) wastes using alcalase. J Mol Catal B Enzym 11:1051\u20131059","journal-title":"J Mol Catal B Enzym"},{"issue":"3","key":"9_CR75","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/jf990447v","volume":"48","author":"HG Kristinsson","year":"2000","unstructured":"Kristinsson HG, Rasco BA (2000) Biochemical and functional properties of Atlantic salmon (Salmo salar) muscle proteins hydrolyzed with various alkaline proteases. J Agric Food Chem 48(3):657\u2013666","journal-title":"J Agric Food Chem"},{"issue":"10","key":"9_CR76","first-page":"96","volume":"45","author":"B Pedersen","year":"1994","unstructured":"Pedersen B (1994) Removing of bitterness from protein hydrolysates. Food Technol 45(10):96\u201398","journal-title":"Food Technol"},{"key":"9_CR77","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jfoodeng.2004.10.011","volume":"70","author":"S Nilsang","year":"2005","unstructured":"Nilsang S, Lertsiri S, Suphantharika M, Assavanig A (2005) Optimization of enzymatic hydrolysis of fish soluble concentrate by commercial proteases. J Food Eng 70:571\u2013578","journal-title":"J Food Eng"},{"key":"9_CR78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/9781118855102.ch9","volume-title":"Antioxidants and functional components in aquatic foods","author":"S Benjakul","year":"2014","unstructured":"Benjakul S, Yarnpakdee S, Senphan T, Halldorsdottir SM, Kristinsson HG (2014) Fish protein hydrolysates: production, bioactivities and applications. In: Kristinsson HG (ed) Antioxidants and functional components in aquatic foods, 1st edn. Matil Ltd, Reykjavik, Iceland, pp 237\u2013283","edition":"1"},{"key":"9_CR79","first-page":"21","volume":"2","author":"F Guerard","year":"2010","unstructured":"Guerard F, Decourcelle N, Sabourin C et al (2010) Recent developments of marine ingredients for food and nutraceutical applications: a review. J Sci Hal Aquat 2:21\u201327","journal-title":"J Sci Hal Aquat"},{"key":"9_CR80","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1201\/b14944-3","volume-title":"Utilization of fish waste","author":"C Cardoso","year":"2013","unstructured":"Cardoso C, Nunes ML (2013) Improved utilization of fish waste, discards, and by-products and low-value fish towards food and health products. In: Galvez RP, Berg\u00e9 J-P (eds) Utilization of fish waste. Taylor & Francis Group, Boca Raton, FL, pp 26\u201358"},{"issue":"3","key":"9_CR81","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1079\/BJN20041189","volume":"92","author":"V Vermeirssen","year":"2004","unstructured":"Vermeirssen V, Van Camp J, Verstraete W (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92(3):357\u2013366","journal-title":"Br J Nutr"},{"key":"9_CR82","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.idairyj.2006.06.004","volume":"16","author":"R L\u00f3pez-Fandi\u00f1o","year":"2006","unstructured":"L\u00f3pez-Fandi\u00f1o R, Otte J, Van Camp J (2006) Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. Int Dairy J 16:1277\u20131293","journal-title":"Int Dairy J"},{"issue":"8","key":"9_CR83","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/138161207780363068","volume":"13","author":"BA Murray","year":"2007","unstructured":"Murray BA, FitzGerald RJ (2007) Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Curr Pharm Des 13(8):773\u2013791","journal-title":"Curr Pharm Des"},{"key":"9_CR84","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.idairyj.2006.06.002","volume":"16","author":"I L\u00f3pez Expo\u00f3sito","year":"2006","unstructured":"L\u00f3pez Expo\u00f3sito I, Recio I (2006) Antibacterial activity of peptides and folding variants from milk proteins. Int Dairy J 16:1294\u20131305","journal-title":"Int Dairy J"},{"key":"9_CR85","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.03.016","volume":"77","author":"E Mendis","year":"2005","unstructured":"Mendis E, Rajapakse N, Byun HG, Kim SK (2005) Investigation of jumbo squid (Dosidicus gigas) skin gelatine peptides for their in vitro antioxidant effects. Life Sci 77:2166\u20132178","journal-title":"Life Sci"},{"issue":"10","key":"9_CR86","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.peptides.2010.06.020","volume":"31","author":"BH Sarmadi","year":"2010","unstructured":"Sarmadi BH, Ismail A (2010) Antioxidative peptides from food proteins: a review. Peptides 31(10):1949\u20131956. https:\/\/doi.org\/10.1016\/j.peptides.2010.06.020","journal-title":"Peptides"},{"issue":"10","key":"9_CR87","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jnutbio.2007.11.010","volume":"19","author":"K Erdmann","year":"2008","unstructured":"Erdmann K, Cheung BW, Schroder H (2008) The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. J Nutr Biochem 19(10):643\u2013654. https:\/\/doi.org\/10.1016\/j.jnutbio.2007.11.010","journal-title":"J Nutr Biochem"},{"key":"9_CR88","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0924-2244(02)00021-3","volume":"12","author":"F Shahidi","year":"2001","unstructured":"Shahidi F, Janak Kamil YVA (2001) Enzymes from fish and aquatic invertebrates and their application in the food industry. Trends Food Sci Technol 12:435\u2013464","journal-title":"Trends Food Sci Technol"},{"key":"9_CR89","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.desal.2008.05.026","volume":"244","author":"PL Bourseau","year":"2009","unstructured":"Bourseau PL, Vandanjon P, Jaouen M et al (2009) Fractionation of fish protein hydrolysates by ultrafiltration and nanofiltration: impact on peptidic populations. Desalination 244:303\u2013320","journal-title":"Desalination"},{"issue":"11","key":"9_CR90","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/jsfa.4020","volume":"90","author":"L Picot","year":"2010","unstructured":"Picot L, Ravallec R, Fouchereau-Peron M et al (2010) Impact of ultrafiltration and nanofiltration of an industrial fish protein hydrolysate on its bioactive properties. J Sci Food Agric 90(11):1819\u20131826. https:\/\/doi.org\/10.1002\/jsfa.4020","journal-title":"J Sci Food Agric"},{"key":"9_CR91","first-page":"20","volume":"63","author":"PK Dutta","year":"2004","unstructured":"Dutta PK, Dutta J, Tripathi VS (2004) Chitin and chitosan: chemistry, properties and applications. J Scientif Indus Res 63:20\u201331","journal-title":"J Scientif Indus Res"},{"key":"9_CR92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0308-8146(02)00180-2","volume":"79","author":"J Kamil","year":"2002","unstructured":"Kamil J, Jeon YJ, Shahidi F (2002) Antioxidant activity of chitosans of different viscosity in cooked comminuted flesh of herring (Clupea harengus). Food Chem 79:69\u201377","journal-title":"Food Chem"},{"issue":"16","key":"9_CR93","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1021\/jf034039+","volume":"51","author":"PJ Park","year":"2003","unstructured":"Park PJ, Je JY, Kim SK (2003) Free radical scavenging activity of chitooligosaccharides by electron spin resonance spectrometry. J Agric Food Chem 51(16):4624\u20134627. https:\/\/doi.org\/10.1021\/jf034039+","journal-title":"J Agric Food Chem"},{"key":"9_CR94","unstructured":"Rosa R, Nunes ML (2008) Crust\u00e1ceos: Explora\u00e7\u00e3o, bioqu\u00edmica, conserva\u00e7\u00e3o e aproveitamento de sub-produtos. Publica\u00e7\u00f5es Avulsas do Instituto de Investiga\u00e7\u00e3o das Pescas e do Mar, IPIMAR, Lisboa, Portugal"},{"issue":"1","key":"9_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10731199009117286","volume":"18","author":"T Chandy","year":"1990","unstructured":"Chandy T, Sharma CP (1990) Chitosan\u2013as a biomaterial. Biomater Artif Cells Artif Organs 18(1):1\u201324","journal-title":"Biomater Artif Cells Artif Organs"},{"key":"9_CR96","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.foodres.2010.06.007","volume":"43","author":"SU Kadam","year":"2010","unstructured":"Kadam SU, Prabhasankar P (2010) Marine foods as functional ingredients in bakery and pasta products. Food Res Int 43:1975\u20131980","journal-title":"Food Res Int"},{"issue":"7","key":"9_CR97","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1002\/biot.200800027","volume":"3","author":"M Hayes","year":"2008","unstructured":"Hayes M, Carney B, Slater J, Bruck W (2008) Mining marine shellfish wastes for bioactive molecules: chitin and chitosan\u2013Part B: applications. Biotechnol J 3(7):878\u2013889. https:\/\/doi.org\/10.1002\/biot.200800027","journal-title":"Biotechnol J"},{"key":"9_CR98","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.foodchem.2006.09.041","volume":"103","author":"C Dawczynski","year":"2007","unstructured":"Dawczynski C, Schubert R, Jahreis G (2007) Amino acids, fatty acids, and dietary fibre in edible seaweed products. Food Chem 103:891\u2013899","journal-title":"Food Chem"},{"key":"9_CR99","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/abio.200390011","volume":"23","author":"BR Mohapatra","year":"2003","unstructured":"Mohapatra BR, Bapuji M, Sree A (2003) Production of industrial enzymes (amylase, carboxymethylcellulase and protease) by bacteria isolated from marine sedentary organizms. Acta Biotechnol 23:75\u201384","journal-title":"Acta Biotechnol"},{"issue":"7","key":"9_CR100","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.3390\/md8072038","volume":"8","author":"L O\u2019Sullivan","year":"2010","unstructured":"O\u2019Sullivan L, Murphy B, McLoughlin P et al (2010) Prebiotics from marine macroalgae for human and animal health applications. Mar Drugs 8(7):2038\u20132064. https:\/\/doi.org\/10.3390\/md8072038","journal-title":"Mar Drugs"},{"key":"9_CR101","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/jsfa.2901","volume":"87","author":"C Devill\u00e9","year":"2007","unstructured":"Devill\u00e9 C, Gharbi M, Dandrifosse G, Peulen O (2007) Study on the effects of laminarin, a polysaccharide from seaweed, on gut characteristics. J Sci Food Agric 87:1717\u20131725","journal-title":"J Sci Food Agric"},{"issue":"3","key":"9_CR102","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mib.2009.04.007","volume":"12","author":"J Courtois","year":"2009","unstructured":"Courtois J (2009) Oligosaccharides from land plants and algae: production and applications in therapeutics and biotechnology. Curr Opin Microbiol 12(3):261\u2013273. https:\/\/doi.org\/10.1016\/j.mib.2009.04.007","journal-title":"Curr Opin Microbiol"},{"key":"9_CR103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.foodres.2008.09.001","volume":"42","author":"Y Wang","year":"2009","unstructured":"Wang Y (2009) Prebiotics: present and future in food science and technology. Food Res Int 42:8\u201312","journal-title":"Food Res Int"},{"key":"9_CR104","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10811-010-9632-5","volume":"23","author":"SL Holdt","year":"2011","unstructured":"Holdt SL, Kraan S (2011) Bioactive compounds in seaweed: functional food applications and legislation. J Appl Phycol 23:543\u2013597","journal-title":"J Appl Phycol"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/B978-0-12-387669-0.00030-2","volume":"64","author":"SK Kim","year":"2011","unstructured":"Kim SK, Li YX (2011) Medicinal benefits of sulfated polysaccharides from sea vegetables. Adv Food Nutr Res 64:391\u2013402. https:\/\/doi.org\/10.1016\/B978-0-12-387669-0.00030-2","journal-title":"Adv Food Nutr Res"},{"key":"9_CR106","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/MMBR.47.4.551-578.1983","volume":"47","author":"O Ciferri","year":"1983","unstructured":"Ciferri O (1983) Spirulina, the edible microorganism (algae, single-cell protein). Microbiol Rev 47:551\u2013578","journal-title":"Microbiol Rev"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.physiol.68.040104.110001","volume":"68","author":"MP Lesser","year":"2006","unstructured":"Lesser MP (2006) Oxidative stress in marine environments: biochemistry and physiological ecology. Annu Rev Physiol 68:253\u2013278. https:\/\/doi.org\/10.1146\/annurev.physiol.68.040104.110001","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"9_CR108","first-page":"355","volume":"16","author":"P Kidd","year":"2011","unstructured":"Kidd P (2011) Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern Med Rev 16(4):355\u2013364","journal-title":"Altern Med Rev"},{"issue":"1003","key":"9_CR109","first-page":"1","volume":"1","author":"Y Yang","year":"2013","unstructured":"Yang Y, Kim B, Lee JY (2013) Astaxanthin structure, metabolism, and health benefits. J Hum Nutr Food Sci 1(1003):1\u201311","journal-title":"J Hum Nutr Food Sci"},{"issue":"10A","key":"9_CR110","doi-asserted-by":"publisher","first-page":"58D","DOI":"10.1016\/j.amjcard.2008.02.010","volume":"101","author":"FJ Pashkow","year":"2008","unstructured":"Pashkow FJ, Watumull DG, Campbell CL (2008) Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am J Cardiol 101(10A):58D\u201368D. https:\/\/doi.org\/10.1016\/j.amjcard.2008.02.010","journal-title":"Am J Cardiol"},{"issue":"5","key":"9_CR111","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0167-7799(03)00078-7","volume":"21","author":"M Guerin","year":"2003","unstructured":"Guerin M, Huntley ME, Olaizola M (2003) Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol 21(5):210\u2013216. https:\/\/doi.org\/10.1016\/S0167-7799(03)00078-7","journal-title":"Trends Biotechnol"},{"issue":"5","key":"9_CR112","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1021\/jf803096g","volume":"57","author":"RL Matsumoto","year":"2009","unstructured":"Matsumoto RL, Bastos DH, Mendonca S et al (2009) Effects of mate tea (Ilex paraguariensis) ingestion on mRNA expression of antioxidant enzymes, lipid peroxidation, and total antioxidant status in healthy young women. J Agric Food Chem 57(5):1775\u20131780. https:\/\/doi.org\/10.1021\/jf803096g","journal-title":"J Agric Food Chem"},{"issue":"14","key":"9_CR113","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.biortech.2004.07.013","volume":"96","author":"SJ Heo","year":"2005","unstructured":"Heo SJ, Park EJ, Lee KW, Jeon YJ (2005) Antioxidant activities of enzymatic extracts from brown seaweeds. Bioresour Technol 96(14):1613\u20131623. https:\/\/doi.org\/10.1016\/j.biortech.2004.07.013","journal-title":"Bioresour Technol"},{"issue":"5","key":"9_CR114","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/1082013210367049","volume":"16","author":"S Cofrades","year":"2010","unstructured":"Cofrades S, Lopez-Lopez I, Bravo L et al (2010) Nutritional and antioxidant properties of different brown and red Spanish edible seaweeds. Food Sci Technol Int\/Ciencia y tecnologia de los alimentos internacional 16(5):361\u2013370. https:\/\/doi.org\/10.1177\/1082013210367049","journal-title":"Food Sci Technol Int\/Ciencia y tecnologia de los alimentos internacional"},{"issue":"5","key":"9_CR115","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.bmc.2009.01.031","volume":"17","author":"Y Li","year":"2009","unstructured":"Li Y, Qian ZJ, Ryu B, Lee SH, Kim MM, Kim SK (2009) Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg Med Chem 17(5):1963\u20131973. https:\/\/doi.org\/10.1016\/j.bmc.2009.01.031","journal-title":"Bioorg Med Chem"},{"issue":"17","key":"9_CR116","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1016\/j.bmc.2008.07.078","volume":"16","author":"M Artan","year":"2008","unstructured":"Artan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK (2008) Anti-HIV-1 activity of phloroglucinol derivative, 6,6\u2032-bieckol, from Ecklonia cava. Bioorg Med Chem 16(17):7921\u20137926. https:\/\/doi.org\/10.1016\/j.bmc.2008.07.078","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"9_CR117","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.fct.2009.04.013","volume":"47","author":"CS Kong","year":"2009","unstructured":"Kong CS, Kim JA, Yoon NY, Kim SK (2009) Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem Toxicol 47(7):1653\u20131658. https:\/\/doi.org\/10.1016\/j.fct.2009.04.013","journal-title":"Food Chem Toxicol"},{"key":"9_CR118","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/B978-0-12-416003-3.00014-7","volume":"65","author":"SK Kim","year":"2012","unstructured":"Kim SK, Karadeniz F (2012) Biological importance and applications of squalene and squalane. Adv Food Nutr Res 65:223\u2013233. https:\/\/doi.org\/10.1016\/B978-0-12-416003-3.00014-7","journal-title":"Adv Food Nutr Res"},{"issue":"22","key":"9_CR119","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1128\/AEM.01402-09","volume":"75","author":"GP Ghimire","year":"2009","unstructured":"Ghimire GP, Lee HC, Sohng JK (2009) Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. Appl Environ Microbiol 75(22):7291\u20137293. https:\/\/doi.org\/10.1128\/AEM.01402-09","journal-title":"Appl Environ Microbiol"},{"issue":"14","key":"9_CR120","doi-asserted-by":"publisher","first-page":"6189","DOI":"10.1021\/jf900673n","volume":"57","author":"F Mantzouridou","year":"2009","unstructured":"Mantzouridou F, Naziri E, Tsimidou MZ (2009) Squalene versus ergosterol formation using Saccharomyces cerevisiae: combined effect of oxygen supply, inoculum size, and fermentation time on yield and selectivity of the bioprocess. J Agric Food Chem 57(14):6189\u20136198. https:\/\/doi.org\/10.1021\/jf900673n","journal-title":"J Agric Food Chem"},{"key":"9_CR121","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1021\/jf034820h","volume":"52","author":"LA Copeman","year":"2004","unstructured":"Copeman LA, Parrish CC (2004) Lipids classes, fatty acids, and sterols in seafood from Gilbert Bay, Southern Labrador. J Agric Food Chem 52:4872\u20134881","journal-title":"J Agric Food Chem"},{"issue":"1","key":"9_CR122","first-page":"50","volume":"12","author":"KJ Murphy","year":"2003","unstructured":"Murphy KJ, Mann NJ, Sinclair AJ (2003) Fatty acid and sterol composition of frozen and freeze-dried New Zealand Green Lipped Mussel (Perna canaliculus) from three sites in New Zealand. Asia Pac J Clin Nutr 12(1):50\u201360","journal-title":"Asia Pac J Clin Nutr"},{"issue":"7","key":"9_CR123","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00394-009-0025-y","volume":"48","author":"HE Rasmussen","year":"2009","unstructured":"Rasmussen HE, Blobaum KR, Jesch ED et al (2009) Hypocholesterolemic effect of Nostoc commune var. sphaeroides Kutzing, an edible blue-green alga. Eur J Nutr 48(7):387\u2013394. https:\/\/doi.org\/10.1007\/s00394-009-0025-y","journal-title":"Eur J Nutr"},{"issue":"10","key":"9_CR124","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.drudis.2015.06.006","volume":"20","author":"EV Patridge","year":"2015","unstructured":"Patridge EV, Gareiss PC, Kinch MS, Hoyer DW (2015) An analysis of original research contributions toward FDA-approved drugs. Drug Discov Today 20(10):1182\u20131187. https:\/\/doi.org\/10.1016\/j.drudis.2015.06.006","journal-title":"Drug Discov Today"},{"key":"9_CR125","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2016.02.008","volume":"40","author":"BECG Goeij de","year":"2016","unstructured":"de Goeij BECG, Lambert JM (2016) New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol 40:14\u201323. https:\/\/doi.org\/10.1016\/j.coi.2016.02.008","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"9_CR126","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.chembiol.2012.12.004","volume":"19","author":"WH Gerwick","year":"2012","unstructured":"Gerwick WH, Moore BS (2012) Lessons from the past and charting the future of marine natural products drug discovery and chemical biology (vol 19, pg 85, 2012). Chem Biol 19(12):1631. https:\/\/doi.org\/10.1016\/j.chembiol.2012.12.004","journal-title":"Chem Biol"},{"issue":"1","key":"9_CR127","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/md12010255","volume":"12","author":"DJ Newman","year":"2014","unstructured":"Newman DJ, Cragg GM (2014) Marine-sourced anti-cancer and cancer pain control agents in clinical and late preclinical development. Mar Drugs 12(1):255\u2013278. https:\/\/doi.org\/10.3390\/md12010255","journal-title":"Mar Drugs"},{"key":"9_CR128","unstructured":"Mayer AMS (2017) Marine pharmaceuticals: the clinical pipeline. http:\/\/marinepharmacology.midwestern.edu\/clinPipeline.htm . Accessed 30 May 2017"},{"key":"9_CR129","unstructured":"FDA (2016) Drugs@FDA: FDA approved drug products. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/ . Accessed 30 Dec 2016"},{"key":"9_CR130","unstructured":"EMA (2016) Medicines. http:\/\/wwwemaeuropaeu\/ema\/indexjsp?curl=pages\/includes\/medicines\/medicines_landing_pagejsp&mid= . Accessed 30 Dec 2016"},{"issue":"2","key":"9_CR131","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bcmd.2012.10.005","volume":"50","author":"MA Lichtman","year":"2013","unstructured":"Lichtman MA (2013) A historical perspective on the development of the cytarabine (7days) and daunorubicin (3days) treatment regimen for acute myelogenous leukemia: 2013 the 40th anniversary of 7+3. Blood Cells Mol Dis 50(2):119\u2013130. https:\/\/doi.org\/10.1016\/j.bcmd.2012.10.005","journal-title":"Blood Cells Mol Dis"},{"issue":"9844","key":"9_CR132","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","volume":"380","author":"KR Shankland","year":"2012","unstructured":"Shankland KR, Armitage JO, Hancock BW (2012) Non-Hodgkin lymphoma. Lancet 380(9844):848\u2013857. https:\/\/doi.org\/10.1016\/S0140-6736(12)60605-9","journal-title":"Lancet"},{"issue":"8","key":"9_CR133","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrd.2016.140","volume":"15","author":"S Cassidy","year":"2016","unstructured":"Cassidy S, Syed BA (2016) Acute myeloid leukaemia drugs market. Nat Rev Drug Discov 15(8):527\u2013528. https:\/\/doi.org\/10.1038\/nrd.2016.140","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"9_CR134","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tips.2010.02.005","volume":"31","author":"AMS Mayer","year":"2010","unstructured":"Mayer AMS, Glaser KB, Cuevas C et al (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 31(6):255\u2013265. https:\/\/doi.org\/10.1016\/j.tips.2010.02.005","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"9_CR135","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1517\/17425247.2010.527330","volume":"7","author":"BS Chhikara","year":"2010","unstructured":"Chhikara BS, Parang K (2010) Development of cytarabine prodrugs and delivery systems for leukemia treatment. Expert Opin Drug Del 7(12):1399\u20131414. https:\/\/doi.org\/10.1517\/17425247.2010.527330","journal-title":"Expert Opin Drug Del"},{"issue":"4","key":"9_CR136","first-page":"397","volume":"3","author":"M Kripp","year":"2008","unstructured":"Kripp M, Hofheinz RD (2008) Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine. Int J Nanomedicine 3(4):397\u2013401","journal-title":"Int J Nanomedicine"},{"key":"9_CR137","unstructured":"National Cancer Institute. In: Clinical Trials (PDQ\u00ae). National Cancer Institute. Accessed 1 Nov 2013"},{"key":"9_CR138","unstructured":"Pharma C. Clavis Pharma announces negative outcome of phase III CLAVELA trial with elacytarabine in patients with acute myeloid leukaemia. http:\/\/aqualis.no\/home . Accessed 1 Nov 2013"},{"issue":"1","key":"9_CR139","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1933","volume":"5","author":"V Gandhi","year":"2006","unstructured":"Gandhi V, Keating MJ, Bate G, Kirkpatrick P (2006) Nelarabine. Nat Rev Drug Discov 5(1):17\u201318","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9_CR140","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bmcl.2008.12.031","volume":"19","author":"W Shen","year":"2009","unstructured":"Shen W, Kim JS, Kish PE et al (2009) Design and synthesis of vidarabine prodrugs as antiviral agents. Bioorg Med Chem Lett 19(3):792\u2013796. https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.031","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"9_CR141","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/Bf01952539","volume":"40","author":"G Cimino","year":"1984","unstructured":"Cimino G, Derosa S, Destefano S (1984) Antiviral agents from a Gorgonian, Eunicella-Cavolini. Experientia 40(4):339\u2013340. https:\/\/doi.org\/10.1007\/Bf01952539","journal-title":"Experientia"},{"issue":"3","key":"9_CR142","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/jm00303a605","volume":"12","author":"J Montgomery","year":"1969","unstructured":"Montgomery J, Hewson K (1969) Nucleosides of 2-Fluoroadenine. J Med Chem 12(3):498\u2013504","journal-title":"J Med Chem"},{"issue":"8","key":"9_CR143","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ctrv.2013.03.006","volume":"39","author":"P Robak","year":"2013","unstructured":"Robak P, Robak T (2013) Older and new purine nucleoside analogs for patients with acute leukemias. Cancer Treat Rev 39(8):851\u2013861","journal-title":"Cancer Treat Rev"},{"key":"9_CR144","first-page":"187","volume":"5","author":"F Ricci","year":"2009","unstructured":"Ricci F, Tedeschi A, Morra E, Montillo M (2009) Fludarabine in the treatment of chronic lymphocytic leukemia: a review. Ther Clin Risk Manag 5:187\u2013207","journal-title":"Ther Clin Risk Manag"},{"key":"9_CR145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molcatb.2016.08.015","volume":"133","author":"MJ Lapponi","year":"2016","unstructured":"Lapponi MJ, Rivero CW, Zinni MA, Britos CN, Trelles JA (2016) New developments in nucleoside analogues biosynthesis: a review. J Mol Catal B Enzym 133:218\u2013233","journal-title":"J Mol Catal B Enzym"},{"key":"9_CR146","doi-asserted-by":"crossref","first-page":"CMT.S1954","DOI":"10.4137\/CMT.S1954","volume":"1","author":"FJ Hernandez-Ilizaliturri","year":"2009","unstructured":"Hernandez-Ilizaliturri FJ, Czuczman MS (2009) A review of nelarabine in the treatment of T-cell lymphoblastic leukemia\/lymphoma. Clin Med Ther 1:CMT.S1954","journal-title":"Clin Med Ther"},{"issue":"6","key":"9_CR147","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1634\/theoncologist.2006-0017","volume":"13","author":"MH Cohen","year":"2008","unstructured":"Cohen MH, Johnson JR, Justice R, Pazdur R (2008) FDA drug approval summary: nelarabine (Arranon(R)) for the treatment of T-Cell lymphoblastic leukemia\/lymphoma. Oncologist 13(6):709\u2013714","journal-title":"Oncologist"},{"issue":"1","key":"9_CR148","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1039\/c3np70058e","volume":"31","author":"A Bauer","year":"2014","unstructured":"Bauer A, Bronstrupt M (2014) Industrial natural product chemistry for drug discovery and development. Nat Prod Rep 31(1):35\u201360. https:\/\/doi.org\/10.1039\/c3np70058e","journal-title":"Nat Prod Rep"},{"key":"9_CR149","unstructured":"Esai C (2016) http:\/\/www.eisai.com . Accessed 6 Dec 2016"},{"issue":"10","key":"9_CR150","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.3390\/toxins7104175","volume":"7","author":"PJ Duggan","year":"2015","unstructured":"Duggan PJ, Tuck KL (2015) Bioactive mimetics of conotoxins and other venom peptides. Toxins 7(10):4175\u20134198. https:\/\/doi.org\/10.3390\/toxins7104175","journal-title":"Toxins"},{"issue":"6994","key":"9_CR151","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/429798a","volume":"429","author":"L Nelson","year":"2004","unstructured":"Nelson L (2004) One slip, and you\u2019re dead\u2026. Nature 429(6994):798\u2013799. https:\/\/doi.org\/10.1038\/429798a","journal-title":"Nature"},{"issue":"24","key":"9_CR152","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.2174\/138161208785777469","volume":"14","author":"TS Han","year":"2008","unstructured":"Han TS, Teichert RW, Olivera BM, Bulaj G (2008) Conus venoms \u2013 a rich source of peptide-based therapeutics. Curr Pharm Des 14(24):2462\u20132479. https:\/\/doi.org\/10.2174\/138161208785777469","journal-title":"Curr Pharm Des"},{"key":"9_CR153","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000062483","volume-title":"Drugs from the sea","author":"BM Oliveira","year":"2000","unstructured":"Oliveira BM (2000) \u03c9-conotoxin MVIIA: from marine snail venom to analgesic drug. In: Fusetani N (ed) Drugs from the sea. Karger, Basel; New York, NY, pp 74\u201385"},{"issue":"1","key":"9_CR154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2009.09.021","volume":"183","author":"JP Bingham","year":"2010","unstructured":"Bingham JP, Mitsunaga E, Bergeron ZL (2010) Drugs from slugs-past, present and future perspectives of omega-conotoxin research. Chem Biol Interact 183(1):1\u201318. https:\/\/doi.org\/10.1016\/j.cbi.2009.09.021","journal-title":"Chem Biol Interact"},{"issue":"17","key":"9_CR155","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1016\/j.bmcl.2013.06.086","volume":"23","author":"RM Brady","year":"2013","unstructured":"Brady RM, Zhang MM, Gable R, Norton RS, Baell JB (2013) De novo design and synthesis of a mu-conotoxin KIIIA peptidomimetic. Bioorg Med Chem Lett 23(17):4892\u20134895. https:\/\/doi.org\/10.1016\/j.bmcl.2013.06.086","journal-title":"Bioorg Med Chem Lett"},{"key":"9_CR156","unstructured":"CORDIS (2016) VENOMICS report summary. http:\/\/cordis.europa.eu\/result\/rcn\/182082_en.html . Accessed 6 Dec 2016"},{"issue":"4A","key":"9_CR157","doi-asserted-by":"publisher","first-page":"71i","DOI":"10.1016\/j.amjcard.2005.12.029","volume":"98","author":"H Bays","year":"2006","unstructured":"Bays H (2006) Clinical overview of omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol 98(4A):71i\u201376i. https:\/\/doi.org\/10.1016\/j.amjcard.2005.12.029","journal-title":"Am J Cardiol"},{"key":"9_CR158","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.vph.2016.03.007","volume":"82","author":"T Gluck","year":"2016","unstructured":"Gluck T, Alter P (2016) Marine omega-3 highly unsaturated fatty acids: from mechanisms to clinical implications in heart failure and arrhythmias. Vasc Pharmacol 82:11\u201319. https:\/\/doi.org\/10.1016\/j.vph.2016.03.007","journal-title":"Vasc Pharmacol"},{"issue":"7","key":"9_CR159","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12325-009-0045-2","volume":"26","author":"H Rupp","year":"2009","unstructured":"Rupp H (2009) OmacorA (R) (prescription omega-3-acid ethyl esters 90): from severe rhythm disorders to hypertriglyceridemia. Adv Ther 26(7):675\u2013690. https:\/\/doi.org\/10.1007\/s12325-009-0045-2","journal-title":"Adv Ther"},{"issue":"5","key":"9_CR160","first-page":"271","volume":"33","author":"RR Koski","year":"2008","unstructured":"Koski RR (2008) Omega-3-acid ethyl esters (lovaza) for severe hypertriglyceridemia. Pharm Therap 33(5):271\u2013303","journal-title":"Pharm Therap"},{"issue":"1","key":"9_CR161","first-page":"143","volume":"11","author":"Charles J Glueck","year":"2012","unstructured":"Glueck CJ, Khan N, Riaz M, Padda J, Khan Z, Wang P (2012) Titrating lovaza from 4 to 8 to 12 grams\/day in patients with primary hypertriglyceridemia who had triglyceride levels > 500 mg\/dl despite conventional triglyceride lowering therapy. Lipids Health Dis 11. doi: https:\/\/doi.org\/10.1186\/1476-511x-11-143","journal-title":"Lipids in Health and Disease"},{"key":"9_CR162","doi-asserted-by":"publisher","unstructured":"Backes J, Anzalone D, Hilleman D, Catini J (2016) The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids Health Dis 15. doi: https:\/\/doi.org\/10.1186\/S12944-016-0286-4","DOI":"10.1186\/S12944-016-0286-4"},{"issue":"8","key":"9_CR163","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1158\/1535-7163.MCT-10-0263","volume":"9","author":"M D\u2019Incalci","year":"2010","unstructured":"D\u2019Incalci M, Galmarini CM (2010) A review of trabectedin (ET-743): A unique mechanism of action. Mol Cancer Ther 9(8):2157\u20132163. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0263","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"9_CR164","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00280-015-2918-1","volume":"77","author":"AK Larsen","year":"2016","unstructured":"Larsen AK, Galmarini CM, D\u2019Incalci M (2016) Unique features of trabectedin mechanism of action. Cancer Chemother Pharmacol 77(4):663\u2013671. https:\/\/doi.org\/10.1007\/s00280-015-2918-1","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"9_CR165","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/bjc.2014.149","volume":"111","author":"M D\u2019Incalci","year":"2014","unstructured":"D\u2019Incalci M, Badri N, Galmarini CM, Allavena P (2014) Trabectedin, a drug acting on both cancer cells and the tumour microenvironment. Br J Cancer 111(4):646\u2013650. https:\/\/doi.org\/10.1038\/bjc.2014.149","journal-title":"Br J Cancer"},{"issue":"1","key":"9_CR166","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A","volume":"20","author":"KL Rinehart","year":"2000","unstructured":"Rinehart KL (2000) Antitumor compounds from tunicates. Med Res Rev 20(1):1\u201327","journal-title":"Med Res Rev"},{"issue":"1","key":"9_CR167","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrd2487","volume":"8","author":"TF Molinski","year":"2009","unstructured":"Molinski TF, Dalisay DS, Lievens SL, Saludes JP (2009) Drug development from marine natural products. Nat Rev Drug Discov 8(1):69\u201385. https:\/\/doi.org\/10.1038\/nrd2487","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"9_CR168","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1039\/b808331m","volume":"26","author":"C Cuevas","year":"2009","unstructured":"Cuevas C, Francesch A (2009) Development of Yondelis (R) (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep 26(3):322\u2013337. https:\/\/doi.org\/10.1039\/b808331m","journal-title":"Nat Prod Rep"},{"key":"9_CR169","unstructured":"Rinehart KL, Holt TG, Fregeau NL et al (1990) Isolation and characterization of the ecteinascidins, potent antitumor compounds from the Caribbean Tunicate Ecteinascidia-Turbinata. Abstr Pap Am Chem S 200:141-ORGN"},{"issue":"15","key":"9_CR170","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1021\/Jo00302a006","volume":"55","author":"AE Wright","year":"1990","unstructured":"Wright AE, Forleo DA, Gunawardana GP, Gunasekera SP, Koehn FE, Mcconnell OJ (1990) Antitumor tetrahydroisoquinoline alkaloids from the colonial Ascidian Ecteinascidia-Turbinata. J Org Chem 55(15):4508\u20134512. https:\/\/doi.org\/10.1021\/Jo00302a006","journal-title":"J Org Chem"},{"issue":"38","key":"9_CR171","doi-asserted-by":"publisher","first-page":"9202","DOI":"10.1021\/Ja962480t","volume":"118","author":"EJ Corey","year":"1996","unstructured":"Corey EJ, Gin DY, Kania RS (1996) Enantioselective total synthesis of ecteinascidin 743. J Am Chem Soc 118(38):9202\u20139203. https:\/\/doi.org\/10.1021\/Ja962480t","journal-title":"J Am Chem Soc"},{"issue":"7","key":"9_CR172","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1021\/Ol0056729","volume":"2","author":"EJ Martinez","year":"2000","unstructured":"Martinez EJ, Corey EJ (2000) A new, more efficient, and effective process for the synthesis of a key pentacyclic intermediate for production of ecteinascidin and phthalascidin antitumor agents. Org Lett 2(7):993\u2013996. https:\/\/doi.org\/10.1021\/Ol0056729","journal-title":"Org Lett"},{"issue":"16","key":"9_CR173","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1021\/Ol0062502","volume":"2","author":"C Cuevas","year":"2000","unstructured":"Cuevas C, Perez M, Martin MJ et al (2000) Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett 2(16):2545\u20132548. https:\/\/doi.org\/10.1021\/Ol0062502","journal-title":"Org Lett"},{"key":"9_CR174","unstructured":"Velasco IA, De La Calle F, Aparicio PT et al (2004) The gene cluster involved in safracin biosynthesis and its uses for genetic engineering. Google Patents"},{"issue":"23","key":"9_CR175","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.1021\/jo034547i","volume":"68","author":"R Menchaca","year":"2003","unstructured":"Menchaca R, Martinez V, Rodriguez A et al (2003) Synthesis of natural ecteinascidins (ET-729, ET-745, ET-759B, ET-736, ET-637, ET-594) from cyanosafracin B. J Org Chem 68(23):8859\u20138866. https:\/\/doi.org\/10.1021\/jo034547i","journal-title":"J Org Chem"},{"issue":"3","key":"9_CR176","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1568011013354561","volume":"1","author":"I Manzanares","year":"2001","unstructured":"Manzanares I, Cuevas C, Garc\u00eda-Nieto R, Marco E, Gago F (2001) Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents. Curr Med Chem Anticancer Agents 1(3):257\u2013276. https:\/\/doi.org\/10.2174\/1568011013354561","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"24","key":"9_CR177","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.2146\/ajhp140773","volume":"72","author":"S Goodin","year":"2015","unstructured":"Goodin S, Barbour S, Song J, Berrak E, Cox D (2015) Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer. Am J Health-Syst Pharm 72(24):2150\u20132156. https:\/\/doi.org\/10.2146\/ajhp140773","journal-title":"Am J Health-Syst Pharm"},{"key":"9_CR178","unstructured":"FDA (2016) FDA approves first drug to show survival benefit in liposarcoma. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm483714.htm . Accessed Dec 2016"},{"issue":"24","key":"9_CR179","doi-asserted-by":"crossref","first-page":"15882","DOI":"10.1016\/S0021-9258(18)98491-7","volume":"266","author":"R Bai","year":"1991","unstructured":"Bai R, Paull KD, Herald CL, Malspeis L, Pettit GR, Hamel E (1991) Halichondrin-B and homohalichondrin-B, marine natural-products binding in the vinca domain of tubulin \u2013 discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J Biol Chem 266(24):15882\u201315889","journal-title":"J Biol Chem"},{"issue":"11","key":"9_CR180","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-14-3252","volume":"21","author":"NF Dybdal-Hargreaves","year":"2015","unstructured":"Dybdal-Hargreaves NF, Risinger AL, Mooberry SL (2015) Eribulin Mesylate: mechanism of action of a unique microtubule-targeting agent. Clin Cancer Res 21(11):2445\u20132452. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3252","journal-title":"Clin Cancer Res"},{"key":"9_CR181","series-title":"Topics in heterocyclic chemistry","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/7081_2016_201","volume-title":"Synthesis of heterocycles in contemporary medicinal chemistry","author":"A Bauer","year":"2016","unstructured":"Bauer A (2016) Story of Eribulin Mesylate: development of the longest drug synthesis. In: \u010casar Z (ed) Synthesis of heterocycles in contemporary medicinal chemistry, Topics in heterocyclic chemistry, vol 44. Springer, Switzerland, pp 209\u2013270"},{"issue":"8","key":"9_CR182","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1021\/Ja00034a086","volume":"114","author":"TD Aicher","year":"1992","unstructured":"Aicher TD, Buszek KR, Fang FG et al (1992) Total synthesis of halichondrin-B and norhalichondrin-B. J Am Chem Soc 114(8):3162\u20133164. https:\/\/doi.org\/10.1021\/Ja00034a086","journal-title":"J Am Chem Soc"},{"issue":"3","key":"9_CR183","first-page":"1013","volume":"61","author":"MJ Towle","year":"2001","unstructured":"Towle MJ, Salvato KA, Budrow J et al (2001) In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res 61(3):1013\u20131021","journal-title":"Cancer Res"},{"issue":"9","key":"9_CR184","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1039\/c3np70051h","volume":"30","author":"MJ Yu","year":"2013","unstructured":"Yu MJ, Zheng WJ, Seletsky BM (2013) From micrograms to grams: scale-up synthesis of eribulin mesylate. Nat Prod Rep 30(9):1158\u20131164. https:\/\/doi.org\/10.1039\/c3np70051h","journal-title":"Nat Prod Rep"},{"issue":"3","key":"9_CR185","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bmc.2011.12.049","volume":"20","author":"KKC Liu","year":"2012","unstructured":"Liu KKC, Sakya SM, O\u2019Donnell CJ, Flick AC, Ding HX (2012) Synthetic approaches to the 2010 new drugs. Bioorg Med Chem 20(3):1155\u20131174. https:\/\/doi.org\/10.1016\/j.bmc.2011.12.049","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"9_CR186","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/phar.1170","volume":"33","author":"AM Newland","year":"2013","unstructured":"Newland AM, Li JX, Wasco LE, Aziz MT, Lowe DK (2013) Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate. Pharmacotherapy 33(1):93\u2013104. https:\/\/doi.org\/10.1002\/phar.1170","journal-title":"Pharmacotherapy"},{"issue":"5","key":"9_CR187","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1039\/c3np20113a","volume":"30","author":"HP Gerber","year":"2013","unstructured":"Gerber HP, Koehn FE, Abraham RT (2013) The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics. Nat Prod Rep 30(5):625\u2013639. https:\/\/doi.org\/10.1039\/c3np20113a","journal-title":"Nat Prod Rep"},{"issue":"1","key":"9_CR188","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1517\/13543784.2011.542147","volume":"20","author":"SM Ansell","year":"2011","unstructured":"Ansell SM (2011) Brentuximab vedotin: delivering an antimitotic drug to activated lymphoma cells. Expert Opin Investig Drugs 20(1):99\u2013105. https:\/\/doi.org\/10.1517\/13543784.2011.542147","journal-title":"Expert Opin Investig Drugs"},{"issue":"22","key":"9_CR189","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1021\/Ja00256a070","volume":"109","author":"GR Pettit","year":"1987","unstructured":"Pettit GR, Kamano Y, Herald CL et al (1987) Antineoplastic agents 136. The isolation and structure of a remarkable marine animal antineoplastic constituent \u2013 Dolastatin 10. J Am Chem Soc 109(22):6883\u20136885. https:\/\/doi.org\/10.1021\/Ja00256a070","journal-title":"J Am Chem Soc"},{"issue":"24","key":"9_CR190","doi-asserted-by":"publisher","first-page":"10527","DOI":"10.1021\/jm501649k","volume":"57","author":"A Maderna","year":"2014","unstructured":"Maderna A, Doroski M, Subramanyam C et al (2014) Discovery of cytotoxic Dolastatin 10 analogues with N-terminal modifications. J Med Chem 57(24):10527\u201310543. https:\/\/doi.org\/10.1021\/jm501649k","journal-title":"J Med Chem"},{"issue":"14","key":"9_CR191","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1021\/Ja00196a061","volume":"111","author":"GR Pettit","year":"1989","unstructured":"Pettit GR, Singh SB, Hogan F et al (1989) Antineoplastic agents 189. The absolute-configuration and synthesis of natural (-)-Dolastatin-10. J Am Chem Soc 111(14):5463\u20135465. https:\/\/doi.org\/10.1021\/Ja00196a061","journal-title":"J Am Chem Soc"},{"issue":"7","key":"9_CR192","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1021\/np010049y","volume":"64","author":"H Luesch","year":"2001","unstructured":"Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH (2001) Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J Nat Prod 64(7):907\u2013910. https:\/\/doi.org\/10.1021\/np010049y","journal-title":"J Nat Prod"},{"issue":"7","key":"9_CR193","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nbt.2289","volume":"30","author":"PD Senter","year":"2012","unstructured":"Senter PD, Sievers EL (2012) The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat Biotechnol 30(7):631\u2013637. https:\/\/doi.org\/10.1038\/nbt.2289","journal-title":"Nat Biotechnol"},{"key":"9_CR194","unstructured":"FDA (2016) ClinicalTrials.gov . https:\/\/clinicaltrials.gov \/. Accessed 30 Dec 2016"},{"key":"9_CR195","unstructured":"EMA (2016) EU clinical trials register. https:\/\/wwwclinicaltrialsregistereu\/ctr-search\/search . Accessed 30 Dec 2016"},{"issue":"12","key":"9_CR196","doi-asserted-by":"publisher","first-page":"e14320","DOI":"10.1371\/journal.pone.0014320","volume":"5","author":"Andreas Leibbrandt","year":"2010","unstructured":"Leibbrandt A, Meier C, Konig-Schuster M et al (2010) Iota-Carrageenan is a potent inhibitor of influenza A virus infection. PLoS One 5(12). https:\/\/doi.org\/10.1371\/journal.pone.0014320","journal-title":"PLoS ONE"},{"key":"9_CR197","doi-asserted-by":"publisher","unstructured":"Eccles R, Meier C, Jawad M, Weinmullner R, Grassauer A, Prieschl-Grassauer E (2010) Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Resp Res 11. https:\/\/doi.org\/10.1186\/1465-9921-11-108","DOI":"10.1186\/1465-9921-11-108"},{"issue":"9","key":"9_CR198","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1128\/AAC.31.9.1388","volume":"31","author":"ME Gonzalez","year":"1987","unstructured":"Gonzalez ME, Alarcon B, Carrasco L (1987) Polysaccharides as antiviral agents \u2013 antiviral activity of Carrageenan. Antimicrob Agents Chemother 31(9):1388\u20131393","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"9_CR199","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1021\/Np990514f","volume":"63","author":"MN Rao","year":"2000","unstructured":"Rao MN, Shinnar AE, Noecker LA et al (2000) Aminosterols from the dogfish shark Squalus-acanthias. J Nat Prod 63(5):631\u2013635. https:\/\/doi.org\/10.1021\/Np990514f","journal-title":"J Nat Prod"},{"issue":"2","key":"9_CR200","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/md20080011","volume":"6","author":"T Noguchi","year":"2008","unstructured":"Noguchi T, Arakawa O (2008) Tetrodotoxin \u2013 distribution and accumulation in aquatic organisms, and cases of human intoxication. Mar Drugs 6(2):220\u2013242. https:\/\/doi.org\/10.3390\/md20080011","journal-title":"Mar Drugs"},{"issue":"24","key":"9_CR201","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1021\/Ja00388a092","volume":"104","author":"GR Pettit","year":"1982","unstructured":"Pettit GR, Herald CL, Doubek DL, Herald DL, Arnold E, Clardy J (1982) Anti-neoplastic agents 86. Isolation and structure of bryostatin-1. J Am Chem Soc 104(24):6846\u20136848. https:\/\/doi.org\/10.1021\/Ja00388a092","journal-title":"J Am Chem Soc"},{"issue":"27","key":"9_CR202","doi-asserted-by":"publisher","first-page":"10164","DOI":"10.1021\/ja404578u","volume":"135","author":"MJ Martin","year":"2013","unstructured":"Martin MJ, Coello L, Fernandez R et al (2013) Isolation and first total synthesis of PM050489 and PM060184, two new marine anticancer compounds. J Am Chem Soc 135(27):10164\u201310171. https:\/\/doi.org\/10.1021\/ja404578u","journal-title":"J Am Chem Soc"},{"issue":"3","key":"9_CR203","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/anie.200390115","volume":"42","author":"RH Feling","year":"2003","unstructured":"Feling RH, Buchanan GO, Mincer TJ, Kauffman CA, Jensen PR, Fenical W (2003) Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew Chem Int Ed 42(3):355. https:\/\/doi.org\/10.1002\/anie.200390115","journal-title":"Angew Chem Int Ed"},{"key":"9_CR204","unstructured":"Fenical W, Jensen PR, Cheng XC (2000) Halimide, a cytotoxic marine natural product, and derivatives thereof. Google Patents"},{"issue":"3","key":"9_CR205","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3390\/Md403255","volume":"4","author":"W Kem","year":"2006","unstructured":"Kem W, Soti F, Wildeboer K et al (2006) The nemertine toxin anabaseine and its derivative DMXBA (GTS21): chemical and pharmacological properties. Mar Drugs 4(3):255\u2013273. https:\/\/doi.org\/10.3390\/Md403255","journal-title":"Mar Drugs"},{"issue":"1","key":"9_CR206","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/md11010146","volume":"11","author":"NV Thomas","year":"2013","unstructured":"Thomas NV, Kim SK (2013) Beneficial effects of marine algal compounds in cosmeceuticals. Mar Drugs 11(1):146\u2013164. https:\/\/doi.org\/10.3390\/md11010146","journal-title":"Mar Drugs"},{"key":"9_CR207","first-page":"2","volume":"2","author":"ASP Kijjoa","year":"2004","unstructured":"Kijjoa ASP (2004) Drugs and cosmetics from the sea. Mar Drugs 2:2","journal-title":"Mar Drugs"},{"issue":"2","key":"9_CR208","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1271\/bbb.70268","volume":"72","author":"YH Kim","year":"2008","unstructured":"Kim YH, Chung CB, Kim JG et al (2008) Anti-wrinkle activity of ziyuglycoside I isolated from a Sanguisorba officinalis root extract and its application as a cosmeceutical ingredient. Biosci Biotechnol Biochem 72(2):303\u2013311. https:\/\/doi.org\/10.1271\/bbb.70268","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"9_CR209","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/md11010233","volume":"11","author":"MF Raposo","year":"2013","unstructured":"Raposo MF, de Morais RM, Bernardo de Morais AM (2013) Bioactivity and applications of sulphated polysaccharides from marine microalgae. Mar Drugs 11(1):233\u2013252. https:\/\/doi.org\/10.3390\/md11010233","journal-title":"Mar Drugs"},{"key":"9_CR210","unstructured":"LIPOTEC (2016) LIPOTEC CATALOGUE. In: LIPOTEC. http:\/\/www.lipotec.com . Accessed 7 Jan 2017"},{"key":"9_CR211","unstructured":"Wire B (2016) http:\/\/www.businesswire.com\/news\/home\/20160323006461\/en\/Global-Cosmeceuticals-Market-Worth-USD-61-Billion . Accessed 5 Jan 2017"},{"issue":"6","key":"9_CR212","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.tifs.2011.03.011","volume":"22","author":"S Gupta","year":"2011","unstructured":"Gupta S, Abu-Ghannam N (2011) Bioactive potential and possible health effects of edible brown seaweeds. Trends Food Sci Technol 22(6):315\u2013326. https:\/\/doi.org\/10.1016\/j.tifs.2011.03.011","journal-title":"Trends Food Sci Technol"},{"issue":"12","key":"9_CR213","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.procbio.2011.09.015","volume":"46","author":"Y-X Li","year":"2011","unstructured":"Li Y-X, Wijesekara I, Li Y, Kim S-K (2011) Phlorotannins as bioactive agents from brown algae. Process Biochem 46(12):2219\u20132224","journal-title":"Process Biochem"},{"issue":"1","key":"9_CR214","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.carbpol.2010.10.062","volume":"84","author":"I Wijesekara","year":"2011","unstructured":"Wijesekara I, Pangestuti R, Kim S-K (2011) Biological activities and potential health benefits of sulfated polysaccharides derived from marine algae. Carbohydr Polym 84(1):14\u201321. https:\/\/doi.org\/10.1016\/j.carbpol.2010.10.062","journal-title":"Carbohydr Polym"},{"issue":"1","key":"9_CR215","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2867-13-55","volume":"13","author":"JC Lee","year":"2013","unstructured":"Lee JC, Hou MF, Huang HW et al (2013) Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int 13(1):55. https:\/\/doi.org\/10.1186\/1475-2867-13-55","journal-title":"Cancer Cell Int"},{"key":"9_CR216","unstructured":"SEPPIC (2016) SEPPIC CATALOGUE. In: SEPPIC GROUP. http:\/\/www.seppic.com\/products-@\/3701\/view-3708-category.html . Accessed 6 Jan 2016"},{"key":"9_CR217","unstructured":"CODIF (2016) DERMOCHLORELLA-D. In: CODIF. http:\/\/www.codif-tn.com\/en\/principesactifs\/dermochlorella-d\/ . Accessed 6 Jan 2017"},{"key":"9_CR218","first-page":"7","volume":"120","author":"P Stolz","year":"2005","unstructured":"Stolz P, Obermayer B (2005) Manufacturing microalgae for skin care. Cosmet Toilet 120:7","journal-title":"Cosmet Toilet"},{"key":"9_CR219","unstructured":"GREENSEA (2016) An unlimited mine of innovation. In: GREENSEA. http:\/\/greensea.fr\/en\/active-ingredients . Accessed 6 Jan 2017"},{"key":"9_CR220","unstructured":"ALGENIST (2016) Patented breakthrough ingredient. In: ALGENIST. https:\/\/algenist.borderfree.com\/-ingredient . Accessed 6 Jan 2017"},{"key":"9_CR221","unstructured":"FRUTAROM (2016) Frutarom. https:\/\/products.frutarom.com\/apex\/f?p=105:1:0 . Accessed 6 Jan 2017"},{"issue":"1","key":"9_CR222","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11802-005-0026-2","volume":"4","author":"Z Chi","year":"2005","unstructured":"Chi Z, Fang Y (2005) Exopolysaccharides from marine bacteria. J Ocean Univ China 4(1):67\u201374. https:\/\/doi.org\/10.1007\/s11802-005-0026-2","journal-title":"J Ocean Univ China"},{"issue":"4","key":"9_CR223","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10126-004-5118-2","volume":"7","author":"CA Nichols","year":"2005","unstructured":"Nichols CA, Guezennec J, Bowman JP (2005) Bacterial exopolysaccharides from extreme marine environments with special consideration of the southern ocean, sea ice, and deep-sea hydrothermal vents: a review. Mar Biotechnol (New York, NY) 7(4):253\u2013271. https:\/\/doi.org\/10.1007\/s10126-004-5118-2","journal-title":"Mar Biotechnol (New York, NY)"},{"issue":"2","key":"9_CR224","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2672.2002.01689.x","volume":"93","author":"MA Cambon-Bonavita","year":"2002","unstructured":"Cambon-Bonavita MA, Raguenes G, Jean J, Vincent P, Guezennec J (2002) A novel polymer produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. J Appl Microbiol 93(2):310\u2013315","journal-title":"J Appl Microbiol"},{"issue":"4","key":"9_CR225","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1099\/00207713-47-4-989","volume":"47","author":"G Raguenes","year":"1997","unstructured":"Raguenes G, Christen R, Guezennec J, Pignet P, Barbier G (1997) Vibrio diabolicus sp. nov., a new polysaccharide-secreting organism isolated from a deep-sea hydrothermal vent polychaete annelid, Alvinella pompejana. Int J Syst Bacteriol 47(4):989\u2013995. https:\/\/doi.org\/10.1099\/00207713-47-4-989","journal-title":"Int J Syst Bacteriol"},{"issue":"1","key":"9_CR226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/AEM.62.1.67-73.1996","volume":"62","author":"G Raguenes","year":"1996","unstructured":"Raguenes G, Pignet P, Gauthier G et al (1996) Description of a new polymer-secreting bacterium from a deep-sea hydrothermal vent, Alteromonas macleodii subsp. fijiensis, and preliminary characterization of the polymer. Appl Environ Microbiol 62(1):67\u201373","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"9_CR227","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2672.1997.00125.x","volume":"82","author":"GH Raguenes","year":"1997","unstructured":"Raguenes GH, Peres A, Ruimy R et al (1997) Alteromonas infernus sp. nov., a new polysaccharide-producing bacterium isolated from a deep-sea hydrothermal vent. J Appl Microbiol 82(4):422\u2013430","journal-title":"J Appl Microbiol"},{"key":"9_CR228","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0008-6215(99)00019-1","volume":"315","author":"HG Rougeaux","year":"1999","unstructured":"Rougeaux HG, Guezennec J, Carlson RW, Kervarec N, Pichon R, Talaga P (1999) Structural determination of the exopolysaccharide of Pseudoalteromonas strain HYD 721 isolated from a deep-sea hydrothermal vent. Carbohydr Res 315:12","journal-title":"Carbohydr Res"},{"issue":"11","key":"9_CR229","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1128\/AEM.60.11.4134-4141.1994","volume":"60","author":"P Vincent","year":"1994","unstructured":"Vincent P, Pignet P, Talmont F et al (1994) Production and characterization of an exopolysaccharide excreted by a deep-sea hydrothermal vent bacterium isolated from the Polychaete Annelid Alvinella pompejana. Appl Environ Microbiol 60(11):4134\u20134141","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"9_CR230","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01569989","volume":"15","author":"R Weiner","year":"1995","unstructured":"Weiner R, Langille S, Quintero E (1995) Structure, function and immunochemistry of bacterial exopolysaccharides. J Ind Microbiol 15(4):339\u2013346","journal-title":"J Ind Microbiol"},{"key":"9_CR231","first-page":"267","volume":"3","author":"DL Desbruyeres","year":"1980","unstructured":"Desbruyeres DL, Laubier L (1980) Alvinella pompejana gen. sp. nov., aberrant Ampharetidae from East Pacific Rise hydrothermal vents. Oceanol Acta 3:267\u2013274","journal-title":"Oceanol Acta"},{"issue":"1","key":"9_CR232","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.carbpol.2012.04.059","volume":"90","author":"T Costaouec Le","year":"2012","unstructured":"Le Costaouec T, Cerantola S, Ropartz D et al (2012) Structural data on a bacterial exopolysaccharide produced by a deep-sea Alteromonas macleodii strain. Carbohydr Polym 90(1):49\u201359. https:\/\/doi.org\/10.1016\/j.carbpol.2012.04.059","journal-title":"Carbohydr Polym"},{"key":"9_CR233","first-page":"7","volume":"34","author":"AT Thibodeau","year":"2006","unstructured":"Thibodeau AT (2006) The applications and functions of new exopolysaccharide \u201cDeepsane\u201d from the deepest oceans. Fragr J 34:7","journal-title":"Fragr J"},{"issue":"12","key":"9_CR234","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1021\/np50090a001","volume":"55","author":"BC Potts","year":"1992","unstructured":"Potts BC, Faulkner DJ, Jacobs RS (1992) Phospholipase A2 inhibitors from marine organisms. J Nat Prod 55(12):1701\u20131717","journal-title":"J Nat Prod"},{"key":"9_CR235","first-page":"12","volume":"11","author":"DR Day","year":"2013","unstructured":"Day DR, Jabaiah S, Jacobs RS, Little RD (2013) Cyclodextrin formulation of the marine natural product pseudopterosin A uncovers optimal pharmacodynamics in proliferation studies of human umbilical vein endothelial cells. Mar Drugs 11:12","journal-title":"Mar Drugs"},{"key":"9_CR236","first-page":"10","volume":"81","author":"AM Rouhi","year":"2003","unstructured":"Rouhi AM (2003) Betting on natural products for cures. Chem Eng News 81:10","journal-title":"Chem Eng News"},{"issue":"8","key":"9_CR237","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/oby.2012.37","volume":"20","author":"SW Hee","year":"2012","unstructured":"Hee SW, Tsai SH, Chang YC et al (2012) The role of nocturnin in early adipogenesis and modulation of systemic insulin resistance in human. Obesity (Silver Spring, MD) 20(8):1558\u20131565. https:\/\/doi.org\/10.1038\/oby.2012.37","journal-title":"Obesity (Silver Spring, MD)"},{"issue":"7","key":"9_CR238","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tem.2012.03.007","volume":"23","author":"JJ Stubblefield","year":"2012","unstructured":"Stubblefield JJ, Terrien J, Green CB (2012) Nocturnin: at the crossroads of clocks and metabolism. Trends Endocrinol Metab 23(7):326\u2013333. https:\/\/doi.org\/10.1016\/j.tem.2012.03.007","journal-title":"Trends Endocrinol Metab"},{"key":"9_CR239","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-7464-0","volume-title":"The biology of glycoproteins","author":"RJ Ivatt","year":"1984","unstructured":"Ivatt RJ (1984) The biology of glycoproteins. Plenum Press, New York, NY"},{"key":"9_CR240","volume-title":"Glycoproteins: their composition, structure and function","author":"A Gottschalk","year":"1972","unstructured":"Gottschalk A (1972) Glycoproteins: their composition, structure and function. Elsevier, New York, NY"},{"issue":"2","key":"9_CR241","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biortech.2005.02.024","volume":"97","author":"LS Senaratne","year":"2006","unstructured":"Senaratne LS, Park PJ, Kim SK (2006) Isolation and characterization of collagen from brown backed toadfish (Lagocephalus gloveri) skin. Bioresour Technol 97(2):191\u2013197. https:\/\/doi.org\/10.1016\/j.biortech.2005.02.024","journal-title":"Bioresour Technol"},{"issue":"1","key":"9_CR242","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10126-010-9294-y","volume":"13","author":"RK Pettit","year":"2011","unstructured":"Pettit RK (2011) Culturability and secondary metabolite diversity of extreme microbes: expanding contribution of deep sea and deep-sea vent microbes to natural product discovery. Mar Biotechnol 13(1):1\u201311. https:\/\/doi.org\/10.1007\/s10126-010-9294-y","journal-title":"Mar Biotechnol"},{"issue":"7","key":"9_CR243","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1359-6446(00)01511-7","volume":"5","author":"A Harvey","year":"2000","unstructured":"Harvey A (2000) Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 5(7):294\u2013300. https:\/\/doi.org\/10.1016\/S1359-6446(00)01511-7","journal-title":"Drug Discov Today"},{"issue":"5","key":"9_CR244","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1039\/c3np70123a","volume":"31","author":"LE Lallier","year":"2014","unstructured":"Lallier LE, McMeel O, Greiber T, Vanagt T, Dobson ADW, Jaspars M (2014) Access to and use of marine genetic resources: understanding the legal framework. Nat Prod Rep 31(5):612\u2013616. https:\/\/doi.org\/10.1039\/c3np70123a","journal-title":"Nat Prod Rep"},{"issue":"2","key":"9_CR245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3390\/metabo2020303","volume":"2","author":"DA Dias","year":"2012","unstructured":"Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2(2):303\u2013336","journal-title":"Metabolites"},{"issue":"12","key":"9_CR246","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1039\/c2np20091k","volume":"29","author":"GM Cragg","year":"2012","unstructured":"Cragg GM, Katz F, David JNA, Rosenthal J (2012) The impact of the United Nations Convention on Biological Diversity on natural products research. Nat Prod Rep 29(12):1407\u20131423. https:\/\/doi.org\/10.1039\/c2np20091k","journal-title":"Nat Prod Rep"},{"issue":"1","key":"9_CR247","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.tox.2005.12.024","volume":"221","author":"OI Aruoma","year":"2006","unstructured":"Aruoma OI (2006) The impact of food regulation on the food supply chain. Toxicology 221(1):119\u2013127. https:\/\/doi.org\/10.1016\/j.tox.2005.12.024","journal-title":"Toxicology"},{"key":"9_CR248","first-page":"26","volume":"17","author":"D Byrne","year":"2003","unstructured":"Byrne D (2003) Health nutrition and labeling. Food Sci Technol 17:26\u201328","journal-title":"Food Sci Technol"},{"issue":"2","key":"9_CR249","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11101-014-9367-z","volume":"14","author":"B David","year":"2015","unstructured":"David B, Wolfender JL, Dias DA (2015) The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev 14(2):299\u2013315. https:\/\/doi.org\/10.1007\/s11101-014-9367-z","journal-title":"Phytochem Rev"},{"issue":"6","key":"9_CR250","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"JP Hughes","year":"2011","unstructured":"Hughes JP, Rees S, Kalindjian SB, Philpott KL (2011) Principles of early drug discovery. Br J Pharmacol 162(6):1239\u20131249. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01127.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9_CR251","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/np100550t","volume":"74","author":"DGI Kingston","year":"2011","unstructured":"Kingston DGI (2011) Modern natural products drug discovery and its relevance to biodiversity conservation. J Nat Prod 74(3):496\u2013511. https:\/\/doi.org\/10.1021\/np100550t","journal-title":"J Nat Prod"},{"issue":"11","key":"9_CR252","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1039\/c1np00033k","volume":"28","author":"GT Carter","year":"2011","unstructured":"Carter GT (2011) Natural products and Pharma 2011: strategic changes spur new opportunities. Nat Prod Rep 28(11):1783\u20131789. https:\/\/doi.org\/10.1039\/c1np00033k","journal-title":"Nat Prod Rep"},{"issue":"9\u201310","key":"9_CR253","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1055\/s-0042-101763","volume":"82","author":"I Perez-Victoria","year":"2016","unstructured":"Perez-Victoria I, Martin J, Reyes F (2016) Combined LC\/UV\/MS and NMR strategies for the dereplication of marine natural products. Planta Med 82(9\u201310):857\u2013871. https:\/\/doi.org\/10.1055\/s-0042-101763","journal-title":"Planta Med"},{"issue":"22","key":"9_CR254","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1016\/j.bmc.2011.07.017","volume":"19","author":"OK Radjasa","year":"2011","unstructured":"Radjasa OK, Vaske YM, Navarro G et al (2011) Highlights of marine invertebrate-derived biosynthetic products: their biomedical potential and possible production by microbial associants. Bioorg Med Chem 19(22):6658\u20136674. https:\/\/doi.org\/10.1016\/j.bmc.2011.07.017","journal-title":"Bioorg Med Chem"},{"key":"9_CR255","doi-asserted-by":"publisher","unstructured":"Hubert J, Nuzillard J-M, Renault J-H (2015) Dereplication strategies in natural product research: how many tools and methodologies behind the same concept? Phytochem Rev. https:\/\/doi.org\/10.1007\/s11101-015-9448-7","DOI":"10.1007\/s11101-015-9448-7"},{"issue":"6","key":"9_CR256","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1039\/c4np00134f","volume":"32","author":"SP Gaud\u00eancio","year":"2015","unstructured":"Gaud\u00eancio SP, Pereira F (2015) Dereplication: racing to speed up the natural products discovery process. Nat Prod Rep 32(6):779\u2013810. https:\/\/doi.org\/10.1039\/c4np00134f","journal-title":"Nat Prod Rep"},{"issue":"7","key":"9_CR257","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1055\/s-0032-1328300","volume":"79","author":"T Michel","year":"2013","unstructured":"Michel T, Halabalaki M, Skaltsounis AL (2013) New concepts, experimental approaches, and dereplication strategies for the discovery of novel phytoestrogens from natural sources. Planta Med 79(7):514\u2013532. https:\/\/doi.org\/10.1055\/s-0032-1328300","journal-title":"Planta Med"},{"key":"9_CR258","volume-title":"Natural compounds as drugs","author":"F Petersen","year":"2008","unstructured":"Petersen F, Amstutz R (2008) Natural compounds as drugs. Birkh\u00e4user, Basel"}],"container-title":["Grand Challenges in Biology and Biotechnology","Grand Challenges in Marine Biotechnology"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-69075-9_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T18:19:49Z","timestamp":1661278789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-69075-9_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319690742","9783319690759"],"references-count":258,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-69075-9_9","relation":{},"ISSN":["2367-1017","2367-1025"],"issn-type":[{"value":"2367-1017","type":"print"},{"value":"2367-1025","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}